Pura Vida Investments, LLC Intra Cellular Therapies, Inc. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $1.84 Million - $2.79 Million	-52,213 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.72 - $42.49 $1.5 Million - $2.22 Million	52,213 New	52,213 $1.95 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $3.5 Million - $4.83 Million	-150,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $2.64 Million - $4.78 Million	150,000 New	150,000 $3.85 Million
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $792,283 - $4.2 Million	-109,130 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $68,201 - $128,093	9,130 Added 9.13%	109,130 $815,000
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $872,000 - $1.13 Million	80,000 Added 400.0%	100,000 $1.22 Million
Q2 2018 Aug 14, 2018	BUY	$17.33 - $23.4 $346,599 - $468,000	20,000 New	20,000 $353,000

380

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.